Finally, although liver fibrosis is a critical aspect of NAFLD progression, we were unable to test the causal relationship between GDF-15 and fibrosis outcomes due to the lack of publicly available GWAS data on NAFLD fibrosis stages, which represents an important avenue for future research. Here, GDF15 is linked to metabolic dysfunction-associated steatotic liver disease.